Business Wire

  1. Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition And Platform Rollout 7/7/2025

    Bio-Rad Laboratories, Inc. a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital PCR (ddPCR) platforms.

  2. STEMCELL Technologies Introduces STEMprep Tissue Dissociator System To Accelerate Research Discoveries 6/27/2025

    To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes.

  3. Galatea Bio And Fabric Genomics Partner To Deliver Comprehensive Genetic Testing For Common Diseases 6/23/2025

    Galatea Bio and Fabric Genomics, a GeneDx company, announced today a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.

  4. Quanterix Expands Reach With IVD And Large Reference Labs 6/23/2025

    Quanterix Corporation a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution partner, HS Biosystems.

  5. QIAGEN And GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership 6/18/2025

    QIAGEN and GENCURIX, Inc. today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a high-performance digital PCR system designed for clinical diagnostics.

  6. Seek Labs Unveils BioSeeker 6/10/2025

    Seek Labs—a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics—today announced BioSeeker, a next-generation AI discovery engine redefining how the world identifies and treats disease.

  7. Bruker Announces Acquisition Of biocrates, A Leader In Mass Spectrometry-Based Quantitative Metabolomics 6/3/2025

    Bruker Corporation today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed.

  8. hc1 Introduces Outreach Optimization Solution To Drive Laboratory Success 6/3/2025

    hc1 introduced today its new Outreach Optimization solution, designed to transform how clinical laboratories expand their outreach programs, strengthen provider relationships, and drive new revenue.

  9. Revvity Introduces New IVD Reference Standards For Monitoring Oncology Diagnostic Testing Workflows 6/2/2025

    Revvity, Inc. today announced the launch of three Mimix reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use.

  10. QIAGEN Expands Portfolio For Minimal Residual Disease (MRD) Testing In Oncology With New Strategic Partnerships 6/2/2025

    QIAGEN today announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics.